Generated by DeepSeek V3.2| santonin | |
|---|---|
| Name | Santonin |
| IUPACName | (3S,3aS,5aS,9bS)-3,5a,9-Trimethyl-3a,4,5,9b-tetrahydro-3H-benzo[g][1]benzofuran-2,8-dione |
| OtherNames | Santonine |
santonin. It is a sesquiterpene lactone historically used as a prominent anthelmintic drug, specifically for expelling roundworm and pinworm infections. The compound is a colorless, crystalline substance derived primarily from the unexpanded flower heads of certain Artemisia species, notably Artemisia maritima and Artemisia cina. Its use has significantly declined due to the development of safer, more effective pharmaceuticals and its association with notable toxic side effects, including a condition known as xanthopsia.
Santonin is classified as a sesquiterpene lactone with the molecular formula C15H18O3. The molecule features a tricyclic structure incorporating a gamma-lactone ring fused to a decalin system. It is optically active, typically crystallizing in colorless, flat prisms that are soluble in organic solvents like chloroform and ethanol but only sparingly soluble in water. Upon exposure to sunlight, the crystals can develop a yellow color due to photochemical decomposition into a colored compound known as photosantonin. Its structure was a significant target for early organic chemistry studies, with key contributions from chemists like Justus von Liebig and Friedrich Wöhler.
The medicinal use of wormseed plants, the source of santonin, dates back to ancient times, documented in works like those of Dioscorides. The active principle was first isolated in a relatively pure crystalline form in 1830 by the German pharmacist Augustin and the French chemist M. Dublanc. Its isolation marked an important milestone in pharmacognosy, providing a standardized active ingredient from a traditional herbal remedy. The commercial production centered on plants from the genus Artemisia, particularly Artemisia maritima (Levant wormseed) cultivated in regions of the Russian Empire and Turkestan. The quest to determine its molecular structure drove decades of research in the 19th and early 20th centuries, involving prominent figures from the University of Giessen and the University of Berlin.
Santonin functioned as a potent anthelmintic, primarily effective against Ascaris lumbricoides (the large human roundworm) and, to a lesser extent, Enterobius vermicularis (pinworm). Its mechanism of action is believed to involve paralyzing the parasites' musculature, detaching them from the intestinal wall and allowing expulsion via peristalsis. It was typically administered as a powder, tablet, or in combination with other purgatives like calomel or senna. For much of the 19th and early 20th centuries, it was a mainstay in the British Pharmacopoeia, United States Pharmacopeia, and other national formularies, representing one of the first specific chemotherapeutic agents for a parasitic disease.
The therapeutic use of santonin was limited by a narrow therapeutic index and a range of adverse effects. Common side effects included nausea, vomiting, diarrhea, and abdominal pain. A characteristic and notorious toxic effect was xanthopsia, a visual disturbance where the patient perceives objects with a yellow tint, sometimes referred to as "yellow vision." Severe overdose could lead to more serious neurotoxicity, including seizures, delirium, and temporary cortical blindness. Fatalities were recorded, particularly in children. These significant risks ultimately led to its replacement by safer anthelmintics like piperazine and later mebendazole.
The complex structure of santonin made it a challenging and prestigious target for total synthesis. The first successful total synthesis was reported in 1954 by the research group of Gilbert Stork at Columbia University, a landmark achievement in synthetic organic chemistry. This work confirmed the proposed structure and stereochemistry. Chemical modification of santonin led to the development of derivatives, such as santonous acid and various hydrogenated forms, in attempts to reduce toxicity while retaining anthelmintic activity. However, none achieved widespread clinical success, as the entire class was superseded by structurally distinct, synthetic agents developed by the modern pharmaceutical industry.
Category:Sesquiterpene lactones Category:Anthelmintics Category:Withdrawn drugs